Western pharmaceutical companies are increasingly acquiring the rights to drugs developed in China to keep pace with the dynamic and state-supported pharmaceutical competition from the country, which poses potential risks for European supply and production. #Pharmaindustrie #Adipositas #Innovation (translated)
















